Get the Stockscreener App
0.2711
12.96%
0.0311
After Hours:
.27
-0.0011
-0.41%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.2711, with a volume of 24.81M.
It is up +12.96% in the last 24 hours and down -34.83% over the past month.
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
See More
Previous Close:
$0.24
Open:
$0.27
24h Volume:
24.81M
Relative Volume:
2.62
Market Cap:
$6.89M
Revenue:
$62.71M
Net Income/Loss:
$-10.48M
P/E Ratio:
-0.4303
EPS:
-0.63
Net Cash Flow:
$-13.77M
1W Performance:
-32.95%
1M Performance:
-34.83%
6M Performance:
-89.02%
1Y Performance:
-96.01%
1-Day Range:
$0.2213
$0.4799
1-Week Range:
$0.2213
$0.52
52-Week Range:
$0.2179
$7.48
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.2711 | 6.89M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
437.87 | 165.21B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
180.62 | 130.05B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
378.99 | 31.91B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
103.59 | 29.01B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.01 | 27.28B | 15.41B | 1.37B | 2.11B | 7.50 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
HighTower Advisors LLC Acquires 57,736 Shares of ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
A Tale of Resilience: ProPhase Labs Inc Amid Stock Market Turbulence - investchronicle.com
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strat - GuruFocus
ProPhase Labs Delays Yearly Report Filing - TipRanks
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - Insider Monkey
Prophase Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ProPhase Labs, Inc. SEC 10-K Report - TradingView
ProPhase Labs Reports 2024 Financial Results and Strategic Shift - TipRanks
Earnings call transcript: ProPhase Labs Q4 2024 earnings miss, stock falls By Investing.com - Investing.com Australia
ProPhase Labs earnings missed by $1.62, revenue topped estimates - Investing.com Canada
Earnings call transcript: ProPhase Labs Q4 2024 earnings miss, stock falls - Investing.com
ProPhase Labs Inc Reports $6.8 Million Revenue and $(2.61) EPS f - GuruFocus
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024 - The Manila Times
ProPhase Labs Pivots Business Model After $53M Loss: Cancer Test Launch Takes Center Stage - Stock Titan
ProPhase Labs (PRPH) Set to Announce FY Earnings, Faces Challenges - GuruFocus.com
An Overview of ProPhase Labs's Earnings - Benzinga
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 - The Manila Times
ProPhase Labs Announces Key Full Year 2024 Financial Results PresentationVirtual Access Available - Stock Titan
ProPhase Labs (PRPH) Projected to Post Earnings on Thursday - Defense World
ProPhase Labs, Inc. CEO Ted Karkus to Present at Q1 Investor Summit Virtual on March 11th - Nasdaq
ProPhase Labs to Present at the Investor Summit Virtual on March 11 - GlobeNewswire
Can ProPhase Labs Convince Investors? CEO Reveals Strategic Vision Next Week - StockTitan
Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now - Yahoo Finance
ProPhase Labs, Inc. to Host Earnings Call - ACCESS Newswire
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News
Deeper Dive: Understanding ProPhase Labs Inc (PRPH) Through its Various Ratios - The Dwinnex
ProPhase Labs Examines Strategic Opportunities to Leverage - GlobeNewswire
ProPhase Labs Focuses On Telehealth And DTC Marketing For Prescription Drug Growth Strategy - Nasdaq
ProPhase Labs examines opportunities to leverage DTC multi-media infrastructure - TipRanks
ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs - The Manila Times
Can ProPhase's Telehealth Pivot Save Its Stock From Delisting? Company Says No Reverse Split Needed - StockTitan
ProPhase Labs (NASDAQ:PRPH) Now Covered by Analysts at StockNews.com - Defense World
ProPhase sharpens focus on direct-to-consumer growth - Investing.com
ProPhase Labs Appoints Stuart Hollenshead as COO - TipRanks
ProPhase Labs Announces Excellent Progress with Crown - GlobeNewswire
ProPhase Labs Targets Immediate Cash Generation With COVID-19 Receivables And Asset Sales - Nasdaq
Can ProPhase Labs Transform $150M in COVID Claims into a $50M Windfall? - StockTitan
ProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting measures - MSN
ProPhase Labs hires Stuart Hollenshead as COO - TipRanks
ProPhase Labs appoints Stu Hollenshead as COO By Investing.com - Investing.com Nigeria
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - GlobeNewswire
ProPhase Labs Appoints Stu Hollenshead as Chief Operating Officer -February 18, 2025 at 09:45 am EST - Marketscreener.com
ProPhase Labs shares rise on cost cutting plans, hires former Barstool Sports COO Stu Hollenshead - Seeking Alpha
ProPhase Labs appoints Stu Hollenshead as COO - Investing.com
Barstool Sports Executive Powerhouse Joins ProPhase Labs: Major Push into 70M Women Health Market - StockTitan
ProPhase Labs FY2024 EPS Estimate Reduced by Diamond Equity - Defense World
ProPhase Labs (NASDAQ:PRPH) Now Covered by StockNews.com - Defense World
ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles - MSN
ProPhase Labs Appoints New Chief Operating Officer - TipRanks
ProPhase Labs appoints new COO amid executive changes By Investing.com - Investing.com South Africa
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):